Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The science: how GLP-1 (and dual GLP-1/GIP) drugs work Glucagon-like peptide-1, or GLP-1, is a hormone your gut releases after you eat
How Retatrutide Compares to Existing Therapies The progression from single to dual to triple agonist therapy represents a clear trend in obesity pharmacotherapy: Semaglutide (GLP-1 agonist): ~1517% weight loss in Phase III (STEP trials) Tirzepatide (GIP + GLP-1 dual agonist): ~2022.5% weight loss in Phase III (SURMOUNT trials) Retatrutide (GIP + GLP-1 + glucagon triple agonist): ~2629% weight loss in Phase III (TRIUMPH-4) Each additional receptor pathway appears to contribute incremental efficacy
However, glutathiones long-term safety and efficacy are a part of ongoing research as scientific evidence stems from smaller clinical trials
Research has studied GHK-Cu for its ability to stimulate hair follicle size, increase hair growth signals, and support the vascularization of scalp tissue that healthy hair growth requires
Are Retatrutide results faster than tirzepatide for adults over 40
.webp)
